Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
We want you to have these strength metrics above this range
| Co-prescribed Drug | Interaction Pathway | Effect on Co-Drug | Severity | Clinical Action | |---|---|---|---|---| | Warfarin | Hepatic CYP2C9 induction (GCGR) | Reduced anticoagulant effect
Experienced providers help bridge that gap with dose titration, side effect management, adherence support, and ongoing monitoring
Retatrutide has a higher overall adverse event burden (6-10% discontinuation), partly because of the unique dysesthesia side effect at higher doses
It was originally developed as a diabetes medication (Ozempic) before the weight loss applications became clear
US$ 20.59
US$ 29.58
US$ 29.54
-(1).png?sfvrsn=c236e848_3)
